• Published

  Dwell time verification in brachytherapy based on time resolved in vivo dosimetry

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

• Published

  Time-resolved in vivo dosimetry for source tracking in brachytherapy

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

View all (22) »

• A new potent vascular disrupting agent which significantly enhances the anti-cancer effect of radiotherapy combined with mild hyperthermia

  Activity: Talk or presentation types › Lecture and oral contribution

• NEW VASCULAR DISRUPTING AGENT – OXI4503 – SIGNIFICANTLY ENCHANCES ANTI-CANCER EFFECT OF RADIOTHERAPY COMBINED WITH MILD HYPERTHERMIA.

  Activity: Talk or presentation types › Lecture and oral contribution

• The Vascular Disrupting Agent OXi4503 predominantly enhances mild hyperthermia

  Activity: Talk or presentation types › Lecture and oral contribution

View all (5) »